They have reliably raised capital at 10c periodically, and been well supported.
The launch is long anticipated, and i reckon a bit more than a bump, but empty the train stations of fence sitters.
But yes, always need to CR these until they get up and roaring. But, i would hope they would be able to CR at a higher price point.
When we are talking about the fear, that not getting on this train early enough, could see all the cheap seats tighten up once and for all.
The prize is so freaking huge. Look at the volumes market we are attempting to infiltrate. X $$$ per test. And the many more, who dont get mams screening, who outside of testing ages, and cultural reasons.
And it is the fear market, a genuine need to detect cancer signatures early. When they finally can give someone a breast test, from a blood sample, detect early before it can be otherwise detected.
Add to My Watchlist
What is My Watchlist?
